Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type

被引:8
作者
Au, Sammy [1 ]
Villamil, Carlos F. [2 ]
Alaghehbandan, Reza [3 ]
Wang, Gang [2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[2] BC Canc Agcy, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Royal Columbian Hosp, Dept Pathol, New Westminster, BC, Canada
关键词
Prostate cancer; Prostatic ductal adenocarcinoma; Prostatic neoplasms; CARCINOMA; RISK;
D O I
10.1016/j.anndiagpath.2019.02.007
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prostatic ductal adenocarcinoma (PDA) is a rare histologic subtype of prostate cancer characterized by large glands lined with tall columnar pseudostratified epithelium. PDA has several architectural patterns, with papillary and cribriform being the most common. The cribriform pattern of acinar carcinoma has shown to be associated with a worse prognosis in terms of disease progression and disease-specific mortality. However, the significance of cribriform pattern in PDA is unknown. In this study, we sought to compare the adverse pathologic features between cribriform-type and non-cribriform-type PDA, and between PDA and acinar carcinoma with Gleason scores 8-10. We identified PDA cases diagnosed between 2008 and 2018 and 428 radical prostatectomy (RP) specimens containing Gleason 8-10 acinar carcinoma. The slides of all PDA cases were reviewed, and pathologic features were recorded. We found that the vast majority of PDA contained admixed acinar carcinoma, with a median percentage of the ductal component of 50% (range 5-100). 29% of PDA was graded as Grade Group 4 and 35.5% as Grade Group 5. At the time of RP, 45.2% of cases presented as pathologic stage T3a and 29% as T3b. Cribriform-type PDA demonstrated a significantly higher likelihood of extraprostatic extension (84% vs 33.3%, p = 0.01), seminal vesical invasion (36% vs 0%, p = 0.04), lymphovascular invasion (40% vs 0%, p = 0.03) and advanced pathologic stage (84% vs 33.3%, p = 0.01) compared to PDA without cribriform architecture. The proportion of stage >= pT3 tumors in PDA was similar compared to that in Gleason 8-10 acinar carcinoma (74.2% vs 70.8%, p = 0.68).
引用
收藏
页码:59 / 62
页数:4
相关论文
共 18 条
  • [1] Prostate Ductal Adenocarcinoma
    Amin, Ali
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (07) : 514 - 521
  • [2] Ductal adenocarcinoma of the prostate diagnosed on needle biopsy - Correlation with clinical and radical prostatectomy findings and progression
    Brinker, DA
    Potter, SR
    Epstein, JI
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (12) : 1471 - 1479
  • [3] Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate
    Herawi, Mehsati
    Epstein, Jonathan I.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (06) : 889 - 894
  • [4] Ductal Adenocarcinoma of the Prostate
    Hertel, Johann D.
    Humphrey, Peter A.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (01) : 277 - 278
  • [5] Histological variants of prostatic carcinoma and their significance
    Humphrey, Peter A.
    [J]. HISTOPATHOLOGY, 2012, 60 (01) : 59 - 74
  • [6] Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer
    Kweldam, Charlotte F.
    Wildhagen, Mark F.
    Steyerberg, Ewout W.
    Bangma, Chris H.
    van der Kwast, Theodorus H.
    van Leenders, Geert J. L. H.
    [J]. MODERN PATHOLOGY, 2015, 28 (03) : 457 - 464
  • [7] Rare histological patterns of prostatic ductal adenocarcinoma
    Lee, Thomas K.
    Miller, Jeremy S.
    Epstein, Jonathan I.
    [J]. PATHOLOGY, 2010, 42 (04) : 319 - 324
  • [8] Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program
    Meeks, Joshua J.
    Zhao, Lee C.
    Cashy, John
    Kundu, Shilajit
    [J]. BJU INTERNATIONAL, 2012, 109 (06) : 831 - 834
  • [9] Ductal Adenocarcinoma of the Prostate: Increased Mortality Risk and Decreased Serum Prostate Specific Antigen
    Morgan, Todd M.
    Welty, Christopher J.
    Vakar-Lopez, Funda
    Lin, Daniel W.
    Wright, Jonathan L.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (06) : 2303 - 2307
  • [10] Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate
    Packiam, Vignesh T.
    Patel, Sanjay G.
    Pariser, Joseph J.
    Richards, Kyle A.
    Weiner, Adam B.
    Paner, Gladell P.
    VanderWeele, David J.
    Zagaja, Gregory P.
    Eggener, Scott E.
    [J]. UROLOGY, 2015, 86 (04) : 777 - 782